title: The role of vasodilators in the prevention and treatment of no-reflow following percutaneous coronary intervention.
abstract: The routine use of vasodilators in patients with acute coronary syndromes or other groups undergoing percutaneous coronary intervention (PCI) cannot be recommended at present. However, in the event of no-reflow occurring following PCI, intracoronary adenosine or verapamil should be administered.
authors.forename: S A
authors.initials: SA
authors.lastname: Harding
mesh_terms: D000241:Adenosine / Q000627:therapeutic use*; D015906:Angioplasty, Balloon, Coronary / Q000379:methods*; D006801:Humans; D008833:Microcirculation / Q000187:drug effects; D009203:Myocardial Infarction / Q000628:therapy*; D015425:Myocardial Reperfusion / Q000379:methods; D014665:Vasodilator Agents / Q000627:therapeutic use*; D014700:Verapamil / Q000627:therapeutic use*
chemical_list: D014665:Vasodilator Agents; D014700:Verapamil; D000241:Adenosine